Read by QxMD icon Read

Revista Española de Cardiología

Costanza Pellegrini, Won-Keun Kim, Andreas Holzamer, Thomas Walther, N Patrick Mayr, Jonathan Michel, Tobias Rheude, Julio Nuñez, Albert M Kasel, Teresa Trenkwalder, Bernhard M Kaess, Michael Joner, Adnan Kastrati, Heribert Schunkert, Michael Hilker, Helge Möllmann, Christian Hengstenberg, Oliver Husser
INTRODUCTION AND OBJECTIVES: A certain degree of prosthesis oversizing (OS) is recommended for the SAPIEN 3 to achieve device success. However, an increase in OS may increase permanent pacemaker implantation (PPI) rates. We therefore investigated the influence of OS on device failure and PPI. METHODS: A total of 804 patients were treated with SAPIEN 3 at 3 centers. Multislice computed tomography-derived OS was calculated and analyzed both as a continuous variable and categorized in 5% increments with -4% to 0% as reference...
July 14, 2018: Revista Española de Cardiología
Manuel Barreiro-Pérez, Laura Galian-Gay, María José Oliva, Teresa López-Fernández, Leopoldo Pérez de Isla
No abstract text is available yet for this article.
July 12, 2018: Revista Española de Cardiología
Alberto Pérez-Castellanos, Manuel Martínez-Sellés, Aitor Uribarri, Carolina Devesa-Cordero, José Carlos Sánchez-Salado, Albert Ariza-Solé, Iago Sousa, Miriam Juárez, Francisco Fernández-Avilés
INTRODUCTION AND OBJECTIVES: Despite therapeutic hypothermia, unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Our objective was to assess the usefulness of the variables obtained in the early moments after resuscitation in the prediction of 6-month prognosis. METHODS: A multicenter study was performed in 3 intensive cardiac care units. The analysis was done in 153 consecutive survivors of out-of-hospital cardiac arrest who underwent targeted temperature management between January 2007 and July 2015...
July 9, 2018: Revista Española de Cardiología
Hugo González Saldivar, Lourdes Vicent Alaminos, Carlos Rodríguez-Pascual, Gonzalo de la Morena, Covadonga Fernández-Golfín, Carmen Amorós, Mario Baquero Alonso, Luis Martínez Dolz, Albert Ariza Solé, Gabriela Guzmán-Martínez, Juan José Gómez-Doblas, Antonio Arribas Jiménez, María Eugenia Fuentes, Laura Galian Gay, Martín Ruiz Ortiz, Pablo Avanzas, Emad Abu-Assi, Tomás Ripoll-Vera, Oscar Díaz-Castro, Eduardo Pozo Osinalde, Eva Bernal, Manuel Martínez-Sellés
INTRODUCTION AND OBJECTIVES: Current therapeutic options for severe aortic stenosis (AS) include transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). Our aim was to describe the prognosis of patients with severe AS after the decision to perform an intervention, to study the variables influencing their prognosis, and to describe the determinants of waiting time > 2 months. METHODS: Subanalysis of the IDEAS (Influence of the Severe Aortic Stenosis Diagnosis) registry in patients indicated for TAVI or SAVR...
July 8, 2018: Revista Española de Cardiología
Alfredo Redondo Diéguez, Belén Cid Álvarez, Alejandro Ávila Carrillo, Fernando Gómez Peña, José Ramón González-Juanatey, Ramiro Trillo Nouche
No abstract text is available yet for this article.
July 3, 2018: Revista Española de Cardiología
Carla Araújo, Olga Laszczyńska, Marta Viana, Paula Dias, Maria Júlia Maciel, Ilídio Moreira, Ana Azevedo
INTRODUCTION AND OBJECTIVES: Despite increased awareness of sex disparities in care and outcomes of acute myocardial infarction (AMI), there appears to have been no consistent attenuation of these differences over the last decade. We investigated differences by sex in management and 30-day mortality using the European Society of Cardiology Acute Cardiovascular Care Association quality indicators (QIs) for AMI. METHODS: Proportions and standard errors of the 20 Acute Cardiovascular Care Association QIs were calculated for 771 patients with AMI who were admitted to the cardiology departments of 2 tertiary hospitals in Portugal between August 2013 and December 2014...
July 3, 2018: Revista Española de Cardiología
Pieter van der Bijl, Tomaž Podlesnikar, Jeroen J Bax, Victoria Delgado
Sudden cardiac death (SCD) accounts for more than 4 million global deaths per year. While it is most commonly caused by coronary artery disease, a final common pathway of ventricular arrhythmias is shared by different etiologies. The most effective primary and secondary prevention strategy is an implantable cardioverter-defibrillator (ICD). The decision to implant an ICD for primary prevention is largely based on a left ventricular ejection fraction ≤ 35%, but this criterion in isolation is neither sensitive nor specific...
June 30, 2018: Revista Española de Cardiología
Amaia Martínez León, Jessica Paola Rugeles Niño, Anahy María Brandy García, César Morís de la Tassa, Luis Caminal Montero, José Rozado Castaño
No abstract text is available yet for this article.
June 30, 2018: Revista Española de Cardiología
Maria Mahmood, Gregory Y H Lip
Both atrial fibrillation (AF) and chronic kidney disease (CKD) are highly prevalent, especially with increasing age and associated comorbidities, such as hypertension, diabetes, heart failure, and vascular disease. The relationship between both AF and CKD seems to be bidirectional: CKD predisposes to AF while onset of AF seems to lead to progression of CKD. Stroke prevention is the cornerstone of AF management, and AF patients with CKD are at higher risk of stroke, mortality, cardiac events, and bleeding. Stroke prevention requires use of oral anticoagulants, which are either vitamin K antagonists (eg, warfarin), or the nonvitamin K antagonist oral anticoagulants (NOACs)...
June 26, 2018: Revista Española de Cardiología
Ignacio J Amat-Santos, Victoria Martin-Yuste, José Antonio Fernández-Díaz, Javier Martin-Moreiras, Juan Caballero-Borrego, Pablo Salinas, Soledad Ojeda, Fernando Rivero, Julio Núñez Villota, Mohsen Mohandes, Daniela Dubois, Francisco Bosa Ojeda, Eva Rumiz, José M de la Torre Hernández, Jesús Jiménez-Mazuecos, Javier Lacunza, Paula Tejedor, Itziar Gómez, Luis R Goncalves-Ramirez, Paol Rojas, Manel Sabaté, Javier Goicolea, Alejandro Diego Nieto, Miriam Jiménez-Fernández, Javier Escaned, Nieves Gonzalo, Laura Pardo, Javier Cuesta, Gema Miñana, Juan Sanchis, Sergio Rojas, Raúl Millán, Beatriz Vaquerizo, Sara Rodríguez, Dae-Hyun Lee, Francisco J Morales, Alejandro Gutiérrez, María López, Jaume Maristany, Juan Rondán, Guillermo Galeote, Zuheir Kabbanni, Sergio Rodríguez, Luis Teruel, Mario Sadaba, Alfonso Jurado, Vicente Mainar, Juan Sánchez-Rubio, Hugo Vinhas, Renato Fernandes
INTRODUCTION AND OBJECTIVES: There is current controversy regarding the benefits of percutaneous recanalization (PCI) of chronic total coronary occlusions (CTO). Our aim was to determine acute and follow-up outcomes in our setting. METHODS: Two-year prospective registry of consecutive patients undergoing PCI of CTO in 24 centers. RESULTS: A total of 1000 PCIs of CTO were performed in 952 patients. Most were symptomatic (81.5%), with chronic ischemic heart disease (59...
June 25, 2018: Revista Española de Cardiología
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, Saleta Fernández-Barbeira, Tim Kinnaird, Albert Ariza-Solé, Sergio Manzano-Fernández, Christian Templin, Lazar Velicki, Ioanna Xanthopoulou, Enrico Cerrato, Giorgio Quadri, Andrea Rognoni, Giacome Boccuzzi, Andrea Montabone, Salma Taha, Alessandro Durante, Sebastiano Gili, Giulia Magnani, Michele Autelli, Alberto Grosso, Pedro Flores Blanco, Alberto Garay, Ferdinando Varbella, Francesco Tommassini, Berenice Caneiro Queija, Rafael Cobas Paz, María Cespón Fernández, Isabel Muñoz Pousa, Diego Gallo, Umberto Morbiducci, Alberto Domínguez-Rodríguez, José Antonio Baz-Alonso, Mariano Valdés, Ángel Cequier, Fiorenzo Gaita, Dimitrios Alexopoulos, Andrés Íñiguez-Romo
INTRODUCTION AND OBJECTIVES: There is little evidence on rates of stent thrombosis (ST) in patients receiving dual antiplatelet therapy (DAPT) with ticagrelor or prasugrel. The aim of this study was to analyze the incidence and predictors of ST after an acute coronary syndrome among patients receiving DAPT with ticagrelor vs prasugrel. METHODS: We used data from the RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction), analyzing a total of 4123 acute coronary syndrome patients discharged with DAPT with ticagrelor or prasugrel in 11 centers in 6 European countries...
June 25, 2018: Revista Española de Cardiología
Raúl Moreno, Almudena Castro, José Luis López-Sendón
No abstract text is available yet for this article.
June 25, 2018: Revista Española de Cardiología
Inmaculada Pérez-Sánchez, María Sabater-Molina, Carmen Muñoz-Esparza, Juan Ramón Gimeno-Blanes
No abstract text is available yet for this article.
June 25, 2018: Revista Española de Cardiología
Gustavo Jiménez Brítez, Laura Sanchis, Ander Regueiro, Manel Sabate, Marta Sitges, Xavier Freixa
No abstract text is available yet for this article.
June 23, 2018: Revista Española de Cardiología
Ignacio Fernández Lozano, Eduardo Pozo Osinalde, Ignacio García Bolao, Soledad Ojeda Pineda, Luis Rodríguez Padial, Andrés Íñiguez Romo
Adequate, updated and functional technology is essential in cardiology. In Spain, the economic scenario has strongly impacted technology renewal programs and obsolescence is a growing problem. The current report attempts to describe the current situation and the conditions that must concur to update, replace or adopt new technologies in the field of cardiology.
June 22, 2018: Revista Española de Cardiología
Antonio Olry de Labry Lima, Vicente Gimeno Ballester, Jesús Francisco Sierra Sánchez, Antonio Matas Hoces, Julio González-Outón, Emilio Jesús Alegre Del Rey
INTRODUCTION AND OBJECTIVES: To analyze the cost-effectiveness ratio and budget impact of treatment with evolocumab (PCSK9 inhibitor) for patients in secondary prevention in the Spanish National Health System. METHODS: A budget impact analysis, decision tree and Markov models were designed under the public health system perspective, based on the only study with morbidity and mortality data (FOURIER). The alternatives compared were evolocumab vs statins, and dual therapy with ezetimibe in 5% of the population...
June 21, 2018: Revista Española de Cardiología
Mariana Castro, João Abecasis, Tiago Nolasco
No abstract text is available yet for this article.
June 18, 2018: Revista Española de Cardiología
Lucas V A Boersma
No abstract text is available yet for this article.
June 18, 2018: Revista Española de Cardiología
German Cediel, Maribel González-Del-Hoyo, Gil Bonet, Anna Carrasquer, Carme Boqué, Alfredo Bardají
No abstract text is available yet for this article.
June 14, 2018: Revista Española de Cardiología
Sebastian Goreczny, Tomasz Moszura, Maciej Lukaszewski, Michał Podgorski, Jadwiga Anna Moll, Paweł Dryzek
No abstract text is available yet for this article.
June 14, 2018: Revista Española de Cardiología
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"